Anti-ErbB3 antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9228021
SERIAL NO

13919582

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVEO PHARMACEUTICALS INC30 WINTER STREET BOSTON MA 02108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bottega, Steve Cambridge, US 10 43
Breault, Lyne Roslindale, US 19 231
Chen, Ting Acton, US 211 4505
DePrima, Michael Somerville, US 6 64
Fleet, Christina Melrose, US 6 64
Gyuris, Jeno Lincoln, US 63 604
Meetze, Kristan Lexington, US 22 178
Tyler, Steven Boston, US 23 672
Vincent, Sylvie Somerville, US 10 85
Wang, Fang Melrose, US 312 3140
Weiler, Solly Newton, US 17 213
Winston,, Jr William M Marlborough, US 32 270
Woo, Jin-Kyeung Newton, US 6 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 5, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00